Study S001188

Megestrol Acetate Versus Liraglutide Plus Megestrol Acetate in Obese Women with Endometrial Atypical Hyperplasia: a Randomized Controlled Pilot Clinical Study

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT04683237
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2; PHASE3
Masking: NONE
Status: WITHDRAWN
Enrollment: 0
Start: 2021-03-20
Primary completion: 2025-11-30
Lead sponsor: Xiaojun Chen
Conditions: Atypical Endometrial Hyperplasia; Obese; Fertility Issues
Interventions: DRUG:Liraglutide Injection; DRUG:Megestrol Acetate 160 MG
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Pathological complete response (CR) rates [From date of randomization until the date of CR, assessed up to 28 weeks.]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.